Literature DB >> 17023219

The long pentraxin PTX3 in vascular pathology.

Alberto Mantovani1, Cecilia Garlanda, Barbara Bottazzi, Giuseppe Peri, Andrea Doni, Yeny Martinez de la Torre, Roberto Latini.   

Abstract

Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. In addition, PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. Thus, the prototypic long pentraxin PTX3 is a multifunctional soluble pattern recognition receptor acting as a non-redundant component of the humoral arm of innate immunity and involved in tuning inflammation, in matrix deposition and female fertility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023219     DOI: 10.1016/j.vph.2006.08.011

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  34 in total

1.  Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Authors:  Elisa R Zanier; Giovanna Brandi; Giuseppe Peri; Luca Longhi; Tommaso Zoerle; Mauro Tettamanti; Cecilia Garlanda; Anna Sigurtà; Serenella Valaperta; Alberto Mantovani; Maria Grazia De Simoni; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

2.  Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis.

Authors:  Gloria Alvarez-Llamas; Tatiana Martín-Rojas; Fernando de la Cuesta; Enrique Calvo; Felix Gil-Dones; Veronica M Dardé; Luis F Lopez-Almodovar; Luis R Padial; Juan-Antonio Lopez; Fernando Vivanco; Maria G Barderas
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

3.  Plasma Pentraxin 3 as a biomarker of metabolic syndrome.

Authors:  Fatih Kardas; Leyla Akın; Selim Kurtoglu; Mustafa Kendirci; Zehra Kardas
Journal:  Indian J Pediatr       Date:  2014-07-29       Impact factor: 1.967

4.  Pathophysiology of thrombosis in myeloproliferative neoplasms.

Authors:  Raffaele Landolfi; Leonardo Di Gennaro
Journal:  Haematologica       Date:  2011-02       Impact factor: 9.941

5.  The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2.

Authors:  Antonio Inforzato; Clair Baldock; Thomas A Jowitt; David F Holmes; Ragnar Lindstedt; Marcella Marcellini; Vincenzo Rivieccio; David C Briggs; Karl E Kadler; Antonio Verdoliva; Barbara Bottazzi; Alberto Mantovani; Giovanni Salvatori; Anthony J Day
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.

Authors:  Michela Zanetti; Alessandra Bosutti; Clara Ferreira; Pierandrea Vinci; Gianni Biolo; Maurizio Fonda; Matteo Valente; Luigi Cattin; Gianfranco Guarnieri; Rocco Barazzoni
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

7.  Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.

Authors:  Shingo Kato; Mitsuko Ochiai; Tomoya Sakurada; Shino Ohno; Kyoko Miyamoto; Mina Sagara; Masataka Ito; Kyoko Takeuchi; Junko Imaki; Kazuro Itoh; Koji Yakabi
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

8.  Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.

Authors:  Hao Wang; Stephen J Atkins; Roshini Fernando; Rui-Li Wei; Terry J Smith
Journal:  Endocrinology       Date:  2015-08-19       Impact factor: 4.736

9.  The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Byung-Ju Shim; Hui-Kyung Jeon; Seung-Jae Lee; Sung-Sik Kim; Mi-Youn Park; Dong-Hyeun Lee; Woo-Seung Shin; Jong-Min Lee; Ho-Joong Youn; Wook-Sung Chung; Ki-Bae Seung
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

10.  Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.

Authors:  Wei Ge; Hai-Lian Wang; Ruo-Peng Sun
Journal:  Eur J Pediatr       Date:  2013-08-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.